Study Highlights the Use of Viruses as Tools for Material Science and Drug Delivery

May 13, 1998

What would you think if your doctor wanted to inject you with a virus as a part of your medical treatment? Though still a long way off, that is just one of the implications of a recent breakthrough by Temple University chemistry professor Trevor Douglas and Montana State University plant pathology professor Mark Young. The results of their research appear in the May 14 issue of Nature.

Douglas and Young have utilized a "gating mechanism" in the protein coats of some simple viruses which allows them to admit and expel organic and inorganic material. Through these "reversible structural transitions" technicians will be able to remove the genetic component of a virus (the DNA or RNA that allows the virus to reproduce) and use the remaining protein coat as a container and delivery system for other substances.

Douglas and Young explain that "In their native state, viruses are protein assemblies which act as host containers for nucleic acid storage and transport. We have subverted this natural function." Their work is, to a large extent, a conceptual breakthrough. To see (and prove) that viruses are substances that can be taken apart, purged of genetic material, reassembled and used as couriers of selected substances is a significant challenge to conventional thinking.

Hope for significant medical advances come from the fact that the two researchers were able to load an organic substance similar to heparin--which is routinely used to treat coronary thrombosis--into cowpea chlorotic mottle virus. Because this phenomenon of gating is possible for a large number of viruses of different shapes and sizes, there is no reason to think that options for drug delivery are limited to any particular class of medicines.

The simple protein coats that Douglas and Young work with can also be "easily and routinely modified by design." This means that the loaded virus can be altered to target certain types of cells (like cancer cells) and holds the promise of being able to deliver drugs to very specific sites.

Young points out that the viruses he and Douglas work with are relatively simple plant viruses which 1) "are incredibly host-specific" and do not use animals as hosts; 2) are routinely and safely eaten by humans as part of vegetable material; and 3) have had their genetic material removed, leaving only a coat which can be used as a container. As such they pose no health threat to humans.

In fact, some of the most interesting implications of this study have nothing to do with traditional biology or biochemistry. Douglas and Young have used the protein coats of viruses as "size and shape constrained" chambers in which minerals crystallize in very specific and precise dimensions. The possibility of creating an unlimited number of homogeneously sized crystals would have a profound impact, for example, on the production of minaturized semiconductors and other patterned materials.
-end-


Temple University

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.